{"gene":"PCSK1N","run_date":"2026-04-29T11:37:58","timeline":{"discoveries":[{"year":2000,"finding":"ProSAAS (encoded by PCSK1N) is a granin-like neuroendocrine peptide precursor that inhibits prohormone convertase 1 (PC1) with an IC50 of 590 nM but does not inhibit PC2; overexpression in AtT-20 cells substantially reduces processing of the endogenous prohormone POMC, and proSAAS is secreted via the regulated pathway.","method":"In vitro enzyme inhibition assay with purified proSAAS; overexpression in AtT-20 cells with POMC processing readout; Western blot and radioimmunoassay","journal":"The Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 1 — in vitro inhibition assay plus cellular overexpression with defined phenotypic readout, foundational discovery paper","pmids":["10632593"],"is_preprint":false},{"year":2000,"finding":"The PC1 inhibitory region of proSAAS maps to an 8–12 residue segment near the C terminus containing a critical Lys-Arg sequence; synthetic peptides from this region are competitive inhibitors of PC1 with Ki values of 14–40 nM; inhibition is slow-binding and pH-dependent (pH 5.5 but not 7.4); a GST fusion containing the inhibitory region binds the 71-kDa but not the 85-kDa form of PC1; proSAAS does not inhibit furin, PACE4, PC5A, or PC7.","method":"Synthetic peptide inhibition assays, GST pulldown with PC1 forms, in vitro kinetic analysis","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis/deletion mapping and multiple orthogonal methods","pmids":["10816562"],"is_preprint":false},{"year":2000,"finding":"The SAAS C-terminal peptide (SAAS CT) contains a hexapeptide sequence that accounts for the vast majority of proSAAS inhibitory potency toward PC1; nanomolar inhibition constants were established; recombinant PC1 can cleave the SAAS CT peptide at a site consistent with cleavage following the inhibitory hexapeptide, indicating that PC1 can process its own inhibitor.","method":"Competitive enzyme inhibition assays, in vitro cleavage with recombinant PC1","journal":"FEBS Letters","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with defined kinetics, replicated in separate lab from Fricker et al. 2000","pmids":["10812060"],"is_preprint":false},{"year":2000,"finding":"In wild-type mouse brain and pituitary, proSAAS is processed into smaller peptides including little SAAS, PEN, and big LEN; processing is partially impaired in Cpe(fat/fat) mice lacking carboxypeptidase E, leading to accumulation of C-terminally extended PEN, which inhibits PC1 activity.","method":"Radioimmunoassay, reverse-phase HPLC, mass spectrometry, gel filtration on wild-type and Cpe(fat/fat) mouse tissues","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical methods in defined genetic mouse model","pmids":["11094058"],"is_preprint":false},{"year":2001,"finding":"The decapeptide proSAAS-(235–244) (VLGALLRVKR) is the most potent competitive PC1 inhibitor (Ki ~9 nM); systematic alanine scanning identified P1 Arg, P2 Lys, and P4 Arg as critical for inhibition; the extended proSAAS-(235–246) is a substrate cleaved by PC1 at KR(244); molecular modeling indicates an extended/poly-l-proline II conformation for the most potent inhibitor.","method":"In vitro enzyme inhibition assays, alanine scanning mutagenesis of synthetic peptides, circular dichroism, molecular modeling","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis combined with in vitro kinetics and structural analysis","pmids":["11435430"],"is_preprint":false},{"year":2001,"finding":"PC2 or furin can cleave the proSAAS C-terminal peptide in vitro; in PC2 null mouse brains, the proSAAS C-terminal peptide is not processed as efficiently as in wild-type, indicating PC2 is partially responsible for this cleavage in vivo.","method":"In vitro cleavage assays with recombinant PC2 and furin, radioimmunoassay on PC2 null mouse brain extracts","journal":"Journal of Neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — in vitro reconstitution plus genetic null mouse model with RIA readout","pmids":["11259501"],"is_preprint":false},{"year":2001,"finding":"The N-terminal domain of proSAAS (residues 1–180) lacks the inhibitory C-terminal peptide but still reduces PC1 activity detected in medium when co-expressed in HEK293 or CHO/PC1 cells, suggesting a proSAAS-mediated inactivation mechanism distinct from C-terminal competitive inhibition; proSAAS-(1-225) slows processing of proopiomelanocortin and proenkephalin in AtT-20 cells without depleting processed peptide stores.","method":"Transient and stable cotransfection in HEK293, CHO/PC1, and AtT-20 cells; PC1 activity assays; pulse-chase","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — clean cellular assays with deletion constructs, but mechanism of N-terminal inactivation remains incompletely characterized","pmids":["11719503"],"is_preprint":false},{"year":2001,"finding":"ProSAAS-derived peptides (SAAS and LEN) are distributed throughout rat brain and co-localize with PC1 in hippocampus, cerebellum, spinal cord, pituitary, and adrenal medulla; in pancreatic islets, SAAS and LEN are enriched in peripheral (alpha/delta) cells while PC1 is in beta cells, suggesting proSAAS may perform functions beyond PC1 inhibition in some cell types.","method":"Immunohistochemistry with antisera to proSAAS-derived peptides and PC1 in rat tissues","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization by immunohistochemistry, functional implications inferred but not directly tested","pmids":["11672612"],"is_preprint":false},{"year":2002,"finding":"Processing of proSAAS in AtT-20 and PC12 cells produces little SAAS, PEN, and big LEN peptides via the regulated secretory pathway (secretion stimulated by secretagogues); cleavage does not require PC1 or PC2 (PC12 cells express neither), implying a furin-like enzyme mediates initial processing; long-term secretagogue treatment increases PC1 mRNA without affecting proSAAS mRNA, demonstrating independent regulation.","method":"Pulse-chase with [3H]leucine, mass spectrometry, reverse-phase HPLC, radioimmunoassay, secretagogue stimulation in AtT-20 and PC12 cells","journal":"The Biochemical Journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing cleavage pathway and regulated secretion","pmids":["11742530"],"is_preprint":false},{"year":2002,"finding":"ProSAAS (encoded by mouse gene Pcsk1n) is broadly expressed during mouse development from E9, with expression in neural tube-derived tissues early and later restricted to neuroendocrine tissues; expression pattern generally overlaps with PC1, consistent with a role as endogenous PC1 inhibitor during development.","method":"Immunohistochemistry with antisera to SAAS and PC1 in mouse embryos E9–E15","journal":"Brain Research Gene Expression Patterns","confidence":"Low","confidence_rationale":"Tier 3 — localization study; functional role inferred from co-distribution with PC1","pmids":["15018810"],"is_preprint":false},{"year":2004,"finding":"In AtT-20 cells, proSAAS expression inhibits both C-terminal PC1 processing and POMC processing under pulse-chase conditions; SAAS CT peptide-propeptide chimeric constructs inhibit zymogen processing in HEK293 cells but not in AtT-20 cells; the PC1 propeptide expressed in trans reduces PC1 C-terminal processing and POMC processing.","method":"Pulse-chase analysis in AtT-20 and HEK293 cells; transient and stable transfection","journal":"The Journal of Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — cell-based assays with multiple constructs, mechanistic interpretation supported by multiple conditions","pmids":["15283695"],"is_preprint":false},{"year":2008,"finding":"ProSAAS orthologs in Xenopus and zebrafish share two conserved 14–16 residue hydrophobic segments predicted to form alpha-helices and two conserved basic convertase cleavage site sequences; both non-mammalian proSAAS proteins inhibit mouse PC1/3 with nanomolar Ki values but not human furin, and are cleaved by PC2 and furin in vitro; both exhibit neural and endocrine tissue distributions.","method":"In vitro enzyme inhibition assays, in vitro cleavage assays with recombinant convertases, sequence alignment, in situ hybridization, PCR","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of inhibition and cleavage across vertebrate orthologs with multiple methods","pmids":["18948394"],"is_preprint":false},{"year":2010,"finding":"In fetal proSAAS knockout mice, prodynorphin undergoes complete adult-like processing instead of the incomplete processing seen in wild-type fetuses where proSAAS intermediates transiently accumulate, demonstrating proSAAS directly inhibits PC1/3 in embryonic brain in vivo; adult proSAAS knockout mice show normal neuropeptide levels but decreased locomotion and male-specific ~10–15% body weight decrease, suggesting adult roles as neuropeptides.","method":"Targeted gene knockout mouse model, peptidomics, radioimmunoassay, open-field locomotion testing, glucose tolerance test","journal":"Journal of Neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with defined molecular phenotype (prodynorphin processing) plus behavioral readouts","pmids":["20367757"],"is_preprint":false},{"year":2010,"finding":"Little SAAS (a proSAAS-derived peptide) is expressed in the densely retinorecipient central SCN, colocalizes with VIP and GRP, and blockade of NMDA receptors or VIP/GRP cognate receptors does not affect little SAAS-induced phase delays of circadian rhythms, placing little SAAS downstream of light/glutamatergic signaling but independent of VIP/GRP action.","method":"Immunohistochemistry with stereological analysis, c-FOS induction, glutamate-stimulated SCN slice recordings, pharmacological blockade","journal":"PloS One","confidence":"Medium","confidence_rationale":"Tier 2 — combination of localization, genetic context, and pharmacological epistasis in brain slices","pmids":["20830308"],"is_preprint":false},{"year":2011,"finding":"Intracerebroventricular injection of antibodies to PEN and big LEN significantly reduces food intake in fasted mice; big LEN produces rapid and reversible inhibition of synaptic glutamate release in hypothalamic paraventricular nucleus neurons in a manner abolished by blocking postsynaptic G protein activity, suggesting involvement of a postsynaptic GPCR and retrograde synaptic messenger.","method":"ICV antibody injection with food intake readout in mice; whole-cell patch clamp of parvocellular neurons with G-protein blockade","journal":"PloS One","confidence":"High","confidence_rationale":"Tier 2 — two orthogonal in vivo and electrophysiological methods with defined molecular mechanism (GPCR-dependent retrograde signaling)","pmids":["22164236"],"is_preprint":false},{"year":2012,"finding":"Pax6 directly binds the Pcsk1n promoter and down-regulates proSAAS (PCSK1N) expression; Pax6 deficiency increases Pcsk1n expression, which in turn reduces PC1/3 C-terminal processing and activity, impairing proinsulin processing; co-knockdown of Pax6 and Pcsk1n rescues proinsulin processing, placing proSAAS downstream of Pax6 in the regulation of glucose metabolism.","method":"Luciferase reporter assays, chromatin immunoprecipitation, EMSA, quantitative RT-PCR, RNAi in MIN6 cells, rescue co-transfection experiments","journal":"PloS One","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing direct transcriptional regulation and genetic epistasis with functional rescue","pmids":["23056534"],"is_preprint":false},{"year":2013,"finding":"ProSAAS efficiently prevents fibrillation of Aβ(1-42) in vitro at molar ratios of 1:10; residues 97–180 are sufficient for anti-aggregation activity against Aβ; recombinant proSAAS in medium and lentiviral proSAAS overexpression both block Aβ(1-42)-induced neurocytotoxicity in Neuro2A cells; proSAAS co-immunoprecipitates with Aβ immunoreactivity in APdE9 mouse brain lysates.","method":"In vitro fibrillation assay (ThT fluorescence), deletion mutagenesis, co-immunoprecipitation from mouse brain, cell viability assay with Neuro2A cells, lentiviral overexpression","journal":"Journal of Neurochemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro reconstitution with mutagenesis mapping plus co-IP and cell-based neuroprotection, multiple orthogonal methods","pmids":["24102330"],"is_preprint":false},{"year":2013,"finding":"ProSAAS blocks fibrillation of human islet amyloid polypeptide (hIAPP) in vitro and blocks hIAPP-induced cytotoxicity on Rin5f cells; structure-function studies identified the N-terminal region of proSAAS as important for this anti-aggregation activity; overexpression of proSAAS in cells also blocks hIAPP cytotoxicity.","method":"In vitro ThT fibrillation assay, cell viability assays, proSAAS overexpression in cells","journal":"FEBS Letters","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro reconstitution with functional cell-based validation, single lab","pmids":["24042052"],"is_preprint":false},{"year":2014,"finding":"ProSAAS-derived peptides PEN and big LEN colocalize with neuropeptide Y in mouse hypothalamus; initial proSAAS cleavage is mediated by furin (and/or furin-like enzymes) in the Golgi/TGN, generating fragments sorted into distinct vesicles for further processing; mutation of furin consensus sites (P4 Arg→Lys) in proSAAS dramatically increased colocalization of PEN and SAAS in AtT-20 cells.","method":"Immunohistochemistry, site-directed mutagenesis of proSAAS furin sites, transfection of mutant proSAAS in AtT-20 cells, confocal colocalization","journal":"PloS One","confidence":"High","confidence_rationale":"Tier 2 — site-directed mutagenesis combined with cellular sorting experiments and colocalization analysis","pmids":["25148519"],"is_preprint":false},{"year":2016,"finding":"PEN (a proSAAS-derived peptide) binds to and activates GPR83, a GPCR in mouse hypothalamus and Neuro2A cells; reduction of GPR83 expression reduces PEN binding and signaling; in brain regions where GPR83 colocalizes with GPR171 (the bigLEN receptor), coexpression alters signaling properties of each receptor, suggesting functional coupling of the two proSAAS-derived neuropeptide systems.","method":"Radioligand binding assays, GPR83 knockdown, signaling assays in Neuro2A cells, colocalization by immunofluorescence, receptor coexpression in cell lines","journal":"Science Signaling","confidence":"High","confidence_rationale":"Tier 2 — receptor deorphanization with binding, knockdown, and functional signaling assays, multiple orthogonal approaches","pmids":["27117253"],"is_preprint":false},{"year":2016,"finding":"ProSAAS potently inhibits α-synuclein fibrillation in vitro; residues 158–180 (containing a largely conserved element) are critical for this bioactivity; proSAAS-encoding lentivirus blocks α-synuclein-induced cytotoxicity in primary nigral dopaminergic neurons; recombinant proSAAS blocks α-synuclein cytotoxicity in SH-SY5Y cells; proSAAS immunoreactivity is associated with aggregated synuclein deposits in Parkinson's disease substantia nigra.","method":"In vitro ThT fibrillation assay, deletion mutagenesis, lentiviral delivery in primary dopaminergic cultures, cell viability assay in SH-SY5Y, immunohistochemistry on human PD brain","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro reconstitution with mutagenesis, primary neuron neuroprotection, and human brain tissue validation","pmids":["27457957"],"is_preprint":false},{"year":2017,"finding":"ProSAAS-derived peptides (big LEN, PEN, little LEN, little SAAS) are decreased in nucleus accumbens and ventral tegmental area following repeated cocaine administration; proSAAS knockout mice fail to sensitize to cocaine and show diminished locomotor sensitization to amphetamine, while conditioned place preference to cocaine is intact, indicating proSAAS peptides contribute to behavioral sensitization but not reward.","method":"Quantitative peptidomics in mouse brain regions, proSAAS knockout mice, open-field locomotion and sensitization tests, conditioned place preference","journal":"Journal of Neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with quantitative peptidomics and defined behavioral phenotypes","pmids":["28881029"],"is_preprint":false},{"year":2019,"finding":"Neuropeptide PEN-GPR83 signaling is implicated in feeding and body weight regulation; GPR83 distribution overlaps with GPR171 (bigLEN receptor) in some brain regions; coexpression alters receptor signaling, supporting a functionally coupled dual neuropeptide system derived from proSAAS (PCSK1N).","method":"Review synthesizing binding assays, knockdown, colocalization, and signaling studies from earlier work","journal":"ACS Chemical Neuroscience","confidence":"Medium","confidence_rationale":"Tier 3 — review paper synthesizing prior experimental findings; no new primary experiments","pmids":["30726666"],"is_preprint":false},{"year":2020,"finding":"Exposure of Neuro2A cells to ER stressors (tunicamycin, thapsigargin), hypoxic stressor (cobalt chloride), or oxidative stressor (sodium arsenite) increases cellular proSAAS mRNA and protein while paradoxically reducing proSAAS secretion, identifying proSAAS as a stress-responsive secretory chaperone.","method":"qRT-PCR, Western blot, ELISA for secreted proSAAS following stressor treatment in Neuro2A cells","journal":"Cell Stress & Chaperones","confidence":"Medium","confidence_rationale":"Tier 3 — consistent results across multiple stressors, single lab, single expression/secretion readout methodology","pmids":["32607937"],"is_preprint":false},{"year":2022,"finding":"Lentiviral proSAAS overexpression in rat substantia nigra profoundly reduces motor asymmetry caused by AAV-mediated human α-synuclein overexpression, accompanied by preservation of nigral TH-positive cells and striatal TH-positive terminals; proSAAS reduces human α-synuclein levels in nigra and striatum; proSAAS also reduces transsynaptic spread of α-synuclein following vagal AAV injection in mice.","method":"Lentiviral/AAV delivery in rat/mouse models, nigral stereology, TH densitometry, immunohistochemistry, behavioral motor battery","journal":"Journal of Parkinson's Disease","confidence":"High","confidence_rationale":"Tier 2 — two independent in vivo rodent models with stereological and behavioral readouts","pmids":["35527562"],"is_preprint":false}],"current_model":"PCSK1N encodes proSAAS, a granin-like neuroendocrine precursor that functions as a potent competitive inhibitor of prohormone convertase 1/3 (PC1/3) via a C-terminal hexapeptide-containing segment (Ki ~9–40 nM), is cleaved by furin in the Golgi/TGN and by secretory granule convertases into bioactive peptides (PEN, big LEN, little SAAS, little LEN) that are secreted via the regulated pathway, acts as a secretory chaperone blocking amyloid aggregation (Aβ, α-synuclein, hIAPP), is transcriptionally repressed by Pax6 to regulate proinsulin processing, and generates the neuropeptide PEN which signals through GPR83 to regulate feeding behavior and modulate behavioral sensitization to psychostimulants."},"narrative":{"teleology":[{"year":2000,"claim":"The discovery that proSAAS is a granin-like PC1 inhibitor that blocks POMC processing and is secreted via the regulated pathway established PCSK1N as an endogenous regulator of prohormone conversion.","evidence":"In vitro enzyme inhibition assays with purified proSAAS, overexpression in AtT-20 cells with POMC processing readout","pmids":["10632593"],"confidence":"High","gaps":["Mechanism of selectivity for PC1 over PC2 not structurally resolved","No in vivo loss-of-function data at this stage"]},{"year":2000,"claim":"Mapping the inhibitory domain to a C-terminal hexapeptide-containing segment with Ki values of 9–40 nM and demonstrating competitive, slow-binding, pH-dependent kinetics defined proSAAS as a secretory-granule-compartment-specific PC1/3 inhibitor.","evidence":"Systematic synthetic peptide inhibition assays, alanine scanning, GST pulldown with PC1 forms, kinetic analysis across multiple labs","pmids":["10816562","10812060","11435430"],"confidence":"High","gaps":["No crystal structure of the proSAAS–PC1/3 complex","Slow-binding mechanism not fully explained at the structural level"]},{"year":2000,"claim":"Identifying proSAAS processing products (little SAAS, PEN, big LEN) in mouse brain and showing impaired processing in Cpe(fat/fat) mice revealed that carboxypeptidase E trims proSAAS-derived peptides and that incompletely processed intermediates retain PC1 inhibitory activity.","evidence":"RIA, RP-HPLC, mass spectrometry on wild-type and Cpe(fat/fat) mouse brain/pituitary","pmids":["11094058"],"confidence":"High","gaps":["Physiological consequences of accumulated PC1-inhibitory intermediates in Cpe-null context not tested"]},{"year":2001,"claim":"Demonstrating that the N-terminal domain of proSAAS (residues 1–180) reduces secreted PC1 activity independently of the C-terminal inhibitory peptide suggested a second mechanism of PC1 regulation, possibly involving chaperone-like or sorting effects.","evidence":"Cotransfection of N-terminal deletion constructs in HEK293, CHO/PC1, and AtT-20 cells with PC1 activity readout","pmids":["11719503"],"confidence":"Medium","gaps":["Molecular mechanism of N-terminal-mediated PC1 inactivation not identified","No binding partner or structural basis established"]},{"year":2002,"claim":"Showing that proSAAS processing in PC12 cells (which lack PC1 and PC2) produces the same peptides as neuroendocrine AtT-20 cells established furin-like enzymes as the initiators of proSAAS cleavage in the Golgi/TGN, upstream of secretory granule convertases.","evidence":"Pulse-chase, mass spectrometry, RP-HPLC, secretagogue stimulation in AtT-20 and PC12 cells","pmids":["11742530"],"confidence":"High","gaps":["Specific furin-family member responsible not definitively identified in vivo"]},{"year":2010,"claim":"ProSAAS knockout mice revealed that proSAAS inhibits PC1/3 in embryonic brain in vivo (prodynorphin is prematurely fully processed in fetal KO brain) but is largely dispensable for adult neuropeptide processing, while uncovering behavioral roles (reduced locomotion, male-specific body weight decrease).","evidence":"Targeted gene knockout mouse, peptidomics, RIA, open-field locomotion, glucose tolerance test","pmids":["20367757"],"confidence":"High","gaps":["Compensatory mechanisms in adult KO not characterized","Neuropeptide receptor mediating locomotor phenotype unknown at this point"]},{"year":2012,"claim":"Identifying Pax6 as a direct transcriptional repressor of PCSK1N that controls PC1/3 activity and proinsulin processing placed proSAAS within a defined transcriptional circuit governing pancreatic beta-cell function.","evidence":"ChIP, EMSA, luciferase reporters, RNAi, and genetic rescue in MIN6 cells","pmids":["23056534"],"confidence":"High","gaps":["In vivo validation in Pax6-haploinsufficient or beta-cell-specific Pcsk1n KO mice not performed","Other transcriptional regulators of PCSK1N not surveyed"]},{"year":2013,"claim":"Demonstrating that proSAAS blocks fibrillation and cytotoxicity of both Aβ(1-42) and hIAPP, and mapping anti-aggregation activity to the N-terminal/central domain (residues 97–180), established proSAAS as an intracellular anti-amyloid chaperone.","evidence":"ThT fibrillation assays, deletion mutagenesis, co-IP from APdE9 mouse brain, cell viability assays in Neuro2A and Rin5f cells","pmids":["24102330","24042052"],"confidence":"High","gaps":["Structural basis of anti-aggregation activity unknown","In vivo relevance in Alzheimer's or type 2 diabetes models not tested at this stage"]},{"year":2014,"claim":"Site-directed mutagenesis of furin consensus sites in proSAAS altered vesicular sorting of PEN and SAAS fragments, establishing that furin-mediated cleavage in the Golgi/TGN directs differential sorting of proSAAS-derived peptides into distinct secretory vesicle populations.","evidence":"Furin site mutagenesis, transfection in AtT-20 cells, confocal colocalization analysis","pmids":["25148519"],"confidence":"High","gaps":["Identity of sorting receptors that distinguish PEN-containing from SAAS-containing vesicles unknown"]},{"year":2016,"claim":"Deorphanizing GPR83 as the receptor for PEN, and showing that GPR83 and GPR171 (big LEN receptor) functionally interact when coexpressed, established a dual neuropeptide signaling system derived entirely from a single proSAAS precursor.","evidence":"Radioligand binding, GPR83 knockdown, signaling assays in Neuro2A cells, receptor coexpression","pmids":["27117253"],"confidence":"High","gaps":["Downstream signaling cascades of PEN-GPR83 in hypothalamic neurons not fully mapped","In vivo confirmation via GPR83 KO with PEN challenge not yet reported"]},{"year":2016,"claim":"Extending the anti-amyloid function to α-synuclein, with mapping of the critical domain (residues 158–180) and demonstration of neuroprotection in primary dopaminergic neurons, positioned proSAAS as a potential therapeutic for synucleinopathies.","evidence":"ThT assay, deletion mutagenesis, lentiviral delivery in primary nigral cultures, immunohistochemistry on human PD substantia nigra","pmids":["27457957"],"confidence":"High","gaps":["Mechanism of chaperone action (holdase vs. sequestration) not resolved","Stoichiometry in vivo unknown"]},{"year":2017,"claim":"ProSAAS knockout mice failed to sensitize to cocaine and amphetamine while retaining reward responses, dissecting proSAAS-derived neuropeptide function into sensitization (dependent) versus reward (independent) behavioral components.","evidence":"Quantitative peptidomics in nucleus accumbens and VTA, KO mouse locomotor sensitization and conditioned place preference","pmids":["28881029"],"confidence":"High","gaps":["Which specific proSAAS-derived peptide(s) and receptor(s) mediate sensitization not determined","Circuit-level mechanism not mapped"]},{"year":2022,"claim":"In vivo lentiviral proSAAS delivery protected nigral dopaminergic neurons from α-synuclein toxicity and reduced transsynaptic α-synuclein spread in two independent rodent models, providing preclinical validation of the anti-amyloid chaperone function.","evidence":"Lentiviral/AAV delivery in rat substantia nigra and mouse vagus nerve models, stereology, TH densitometry, behavioral motor tests","pmids":["35527562"],"confidence":"High","gaps":["Long-term efficacy and dose-response not established","Mechanism of reduced spread (extracellular chaperone vs. intracellular degradation) not distinguished"]},{"year":null,"claim":"The structural basis of proSAAS interaction with both PC1/3 and amyloidogenic substrates, the identity of sorting receptors directing proSAAS-derived peptides to distinct vesicle populations, and the circuit-level mechanisms by which PEN/GPR83 and bigLEN/GPR171 regulate behavior remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of proSAAS or its complexes","Sorting receptor for proSAAS-derived peptide vesicles not identified","Circuit-specific functions of PEN vs. big LEN signaling not dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2,4,11]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[16,17,20,24]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[19]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[8,18]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0,8,18]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,8,14]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,2,3,12,15]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[19,22]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[14,19,21]}],"complexes":[],"partners":["PCSK1","PCSK2","FURIN","CPE","GPR83","PAX6"],"other_free_text":[]},"mechanistic_narrative":"PCSK1N encodes proSAAS, a neuroendocrine secretory precursor that serves dual roles as a potent competitive inhibitor of prohormone convertase 1/3 (PC1/3) and as a precursor to bioactive neuropeptides regulating feeding, circadian rhythms, and psychostimulant sensitization. The C-terminal segment of proSAAS contains a hexapeptide that competitively inhibits PC1/3 with nanomolar affinity (Ki ~9–40 nM), while the N-terminal domain independently reduces PC1/3 activity through a distinct mechanism; initial cleavage by furin in the Golgi/TGN generates fragments (PEN, big LEN, little SAAS, little LEN) that are sorted into regulated secretory granules and further processed by PC2 and carboxypeptidase E [PMID:10632593, PMID:10816562, PMID:25148519, PMID:11094058]. ProSAAS-derived peptide PEN signals through GPR83 and big LEN through GPR171 to regulate hypothalamic feeding circuits and behavioral sensitization to psychostimulants, while the transcription factor Pax6 directly represses PCSK1N to control proinsulin processing via PC1/3 in pancreatic beta cells [PMID:27117253, PMID:28881029, PMID:23056534]. ProSAAS also functions as an anti-amyloid chaperone that blocks fibrillation and cytotoxicity of Aβ, α-synuclein, and hIAPP through its N-terminal/central domain, and lentiviral proSAAS delivery protects nigral dopaminergic neurons and reduces α-synuclein pathology and spread in rodent Parkinson's disease models [PMID:24102330, PMID:27457957, PMID:35527562]."},"prefetch_data":{"uniprot":{"accession":"Q9UHG2","full_name":"ProSAAS","aliases":["Proprotein convertase subtilisin/kexin type 1 inhibitor","Proprotein convertase 1 inhibitor","pro-SAAS"],"length_aa":260,"mass_kda":27.4,"function":"May function in the control of the neuroendocrine secretory pathway. Proposed be a specific endogenous inhibitor of PCSK1. ProSAAS and Big PEN-LEN, both containing the C-terminal inhibitory domain, but not the further processed peptides reduce PCSK1 activity in the endoplasmic reticulum and Golgi. It reduces the activity of the 84 kDa form but not the autocatalytically derived 66 kDa form of PCSK1. Subsequent processing of proSAAS may eliminate the inhibition. Slows down convertase-mediated processing of proopiomelanocortin and proenkephalin. May control the intracellular timing of PCSK1 rather than its total level of activity (By similarity) Endogenous ligand for GPR171. Neuropeptide involved in the regulation of feeding Endogenous ligand for GPR83. Neuropeptide involved in the regulation of feeding","subcellular_location":"Secreted; Golgi apparatus, trans-Golgi network","url":"https://www.uniprot.org/uniprotkb/Q9UHG2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PCSK1N","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PCSK1N","total_profiled":1310},"omim":[{"mim_id":"618925","title":"G PROTEIN-COUPLED RECEPTOR 171; GPR171","url":"https://www.omim.org/entry/618925"},{"mim_id":"300399","title":"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1, INHIBITOR OF; PCSK1N","url":"https://www.omim.org/entry/300399"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":782.7},{"tissue":"pituitary gland","ntpm":1213.3}],"url":"https://www.proteinatlas.org/search/PCSK1N"},"hgnc":{"alias_symbol":["SAAS","SgVIII","SCG8","proSAAS","PEN","BigLEN"],"prev_symbol":[]},"alphafold":{"accession":"Q9UHG2","domains":[{"cath_id":"1.20.5","chopping":"67-114","consensus_level":"medium","plddt":91.2085,"start":67,"end":114}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UHG2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHG2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHG2-F1-predicted_aligned_error_v6.png","plddt_mean":58.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PCSK1N","jax_strain_url":"https://www.jax.org/strain/search?query=PCSK1N"},"sequence":{"accession":"Q9UHG2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UHG2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UHG2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UHG2"}},"corpus_meta":[{"pmid":"12691659","id":"PMC_12691659","title":"Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex.","date":"2003","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/12691659","citation_count":807,"is_preprint":false},{"pmid":"12740439","id":"PMC_12740439","title":"Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12740439","citation_count":655,"is_preprint":false},{"pmid":"12198112","id":"PMC_12198112","title":"PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12198112","citation_count":244,"is_preprint":false},{"pmid":"15456764","id":"PMC_15456764","title":"Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15456764","citation_count":209,"is_preprint":false},{"pmid":"10632593","id":"PMC_10632593","title":"Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10632593","citation_count":206,"is_preprint":false},{"pmid":"18765289","id":"PMC_18765289","title":"Inteferons pen the JAK-STAT pathway.","date":"2008","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18765289","citation_count":203,"is_preprint":false},{"pmid":"12496430","id":"PMC_12496430","title":"Proteomics and immunological analysis of a novel shrimp allergen, Pen m 2.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12496430","citation_count":192,"is_preprint":false},{"pmid":"11893851","id":"PMC_11893851","title":"Identification of continuous, allergenic regions of the major shrimp allergen Pen a 1 (tropomyosin).","date":"2002","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11893851","citation_count":151,"is_preprint":false},{"pmid":"14717586","id":"PMC_14717586","title":"Detergent-dependent dissociation of active gamma-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex.","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14717586","citation_count":113,"is_preprint":false},{"pmid":"15039426","id":"PMC_15039426","title":"Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15039426","citation_count":104,"is_preprint":false},{"pmid":"32319753","id":"PMC_32319753","title":"Evolution of Dip-Pen Nanolithography (DPN): From Molecular Patterning to Materials Discovery.","date":"2020","source":"Chemical reviews","url":"https://pubmed.ncbi.nlm.nih.gov/32319753","citation_count":100,"is_preprint":false},{"pmid":"18814174","id":"PMC_18814174","title":"Multiplexed lipid dip-pen nanolithography on subcellular scales for the templating of functional proteins and cell culture.","date":"2008","source":"Small (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/18814174","citation_count":98,"is_preprint":false},{"pmid":"16436150","id":"PMC_16436150","title":"Pen ch 13 allergen induces secretion of mediators and degradation of occludin protein of human lung epithelial cells.","date":"2006","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/16436150","citation_count":95,"is_preprint":false},{"pmid":"10816562","id":"PMC_10816562","title":"The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10816562","citation_count":82,"is_preprint":false},{"pmid":"12639958","id":"PMC_12639958","title":"Membrane topology of gamma-secretase component PEN-2.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12639958","citation_count":78,"is_preprint":false},{"pmid":"1648137","id":"PMC_1648137","title":"Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.","date":"1991","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1648137","citation_count":68,"is_preprint":false},{"pmid":"27117253","id":"PMC_27117253","title":"Identification of GPR83 as the receptor for the neuroendocrine peptide PEN.","date":"2016","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/27117253","citation_count":67,"is_preprint":false},{"pmid":"14724271","id":"PMC_14724271","title":"Pen-2 is sequestered in the endoplasmic reticulum and subjected to ubiquitylation and proteasome-mediated degradation in the absence of presenilin.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14724271","citation_count":67,"is_preprint":false},{"pmid":"12238917","id":"PMC_12238917","title":"A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge.","date":"2002","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12238917","citation_count":66,"is_preprint":false},{"pmid":"10812060","id":"PMC_10812060","title":"The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10812060","citation_count":64,"is_preprint":false},{"pmid":"7996550","id":"PMC_7996550","title":"Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).","date":"1994","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7996550","citation_count":62,"is_preprint":false},{"pmid":"15975090","id":"PMC_15975090","title":"Ubiquilin regulates presenilin endoproteolysis and modulates gamma-secretase components, Pen-2 and nicastrin.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15975090","citation_count":61,"is_preprint":false},{"pmid":"9130534","id":"PMC_9130534","title":"Characterization of recombinant shrimp allergen Pen a 1 (tropomyosin).","date":"1997","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9130534","citation_count":54,"is_preprint":false},{"pmid":"10591155","id":"PMC_10591155","title":"Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-[4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]-phenoxy]-pen tane (AMG-126737).","date":"1999","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10591155","citation_count":54,"is_preprint":false},{"pmid":"15248287","id":"PMC_15248287","title":"Functional reconstitution of gamma-secretase through coordinated expression of presenilin, nicastrin, Aph-1, and Pen-2.","date":"2004","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/15248287","citation_count":54,"is_preprint":false},{"pmid":"22164236","id":"PMC_22164236","title":"ProSAAS-derived peptides are colocalized with neuropeptide Y and function as neuropeptides in the regulation of food intake.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22164236","citation_count":53,"is_preprint":false},{"pmid":"15322109","id":"PMC_15322109","title":"Both the sequence and length of the C terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15322109","citation_count":53,"is_preprint":false},{"pmid":"35720388","id":"PMC_35720388","title":"Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE).","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35720388","citation_count":52,"is_preprint":false},{"pmid":"21613216","id":"PMC_21613216","title":"The protease allergen Pen c 13 induces allergic airway inflammation and changes in epithelial barrier integrity and function in a murine model.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21613216","citation_count":51,"is_preprint":false},{"pmid":"25734516","id":"PMC_25734516","title":"17β-Estradiol increases persistent Na(+) current and excitability of AVPV/PeN Kiss1 neurons in female mice.","date":"2015","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/25734516","citation_count":49,"is_preprint":false},{"pmid":"11435430","id":"PMC_11435430","title":"Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11435430","citation_count":48,"is_preprint":false},{"pmid":"11094058","id":"PMC_11094058","title":"ProSAAS processing in mouse brain and pituitary.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11094058","citation_count":47,"is_preprint":false},{"pmid":"16429461","id":"PMC_16429461","title":"Protein nanoarray on Prolinker surface constructed by atomic force microscopy dip-pen nanolithography for analysis of protein interaction.","date":"2006","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/16429461","citation_count":44,"is_preprint":false},{"pmid":"11259501","id":"PMC_11259501","title":"Tissue distribution and processing of proSAAS by proprotein convertases.","date":"2001","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11259501","citation_count":43,"is_preprint":false},{"pmid":"24102330","id":"PMC_24102330","title":"A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease.","date":"2013","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24102330","citation_count":43,"is_preprint":false},{"pmid":"23554307","id":"PMC_23554307","title":"Interdigitated multicolored bioink micropatterns by multiplexed polymer pen lithography.","date":"2013","source":"Small (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/23554307","citation_count":43,"is_preprint":false},{"pmid":"16630158","id":"PMC_16630158","title":"Structural, immunological and functional properties of natural recombinant Pen a 1, the major allergen of Brown Shrimp, Penaeus aztecus.","date":"2006","source":"Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16630158","citation_count":43,"is_preprint":false},{"pmid":"27457957","id":"PMC_27457957","title":"The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27457957","citation_count":42,"is_preprint":false},{"pmid":"30735385","id":"PMC_30735385","title":"Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo.","date":"2019","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30735385","citation_count":42,"is_preprint":false},{"pmid":"11719503","id":"PMC_11719503","title":"Functional characterization of ProSAAS: similarities and differences with 7B2.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11719503","citation_count":39,"is_preprint":false},{"pmid":"11742530","id":"PMC_11742530","title":"Processing of proSAAS in neuroendocrine cell lines.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11742530","citation_count":39,"is_preprint":false},{"pmid":"20367757","id":"PMC_20367757","title":"The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation.","date":"2010","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20367757","citation_count":39,"is_preprint":false},{"pmid":"11672612","id":"PMC_11672612","title":"Distribution of proSAAS-derived peptides in rat neuroendocrine tissues.","date":"2001","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11672612","citation_count":39,"is_preprint":false},{"pmid":"31527825","id":"PMC_31527825","title":"Tracking a mass mortality outbreak of pen shell Pinna nobilis populations: A collaborative effort of scientists and citizens.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31527825","citation_count":39,"is_preprint":false},{"pmid":"21296884","id":"PMC_21296884","title":"Functional and topological analysis of Pen-2, the fourth subunit of the gamma-secretase complex.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21296884","citation_count":38,"is_preprint":false},{"pmid":"15035625","id":"PMC_15035625","title":"Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation.","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15035625","citation_count":36,"is_preprint":false},{"pmid":"31646727","id":"PMC_31646727","title":"Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER).","date":"2019","source":"Diabetes, obesity & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31646727","citation_count":35,"is_preprint":false},{"pmid":"23685131","id":"PMC_23685131","title":"Ferritin light chain interacts with PEN-2 and affects γ-secretase activity.","date":"2013","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/23685131","citation_count":35,"is_preprint":false},{"pmid":"16449647","id":"PMC_16449647","title":"Transcriptional regulation of PEN-2, a key component of the gamma-secretase complex, by CREB.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16449647","citation_count":34,"is_preprint":false},{"pmid":"28409640","id":"PMC_28409640","title":"Polymer-Pen Chemical Lift-Off Lithography.","date":"2017","source":"Nano letters","url":"https://pubmed.ncbi.nlm.nih.gov/28409640","citation_count":34,"is_preprint":false},{"pmid":"23748521","id":"PMC_23748521","title":"Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial.","date":"2013","source":"Postgraduate medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23748521","citation_count":34,"is_preprint":false},{"pmid":"20830308","id":"PMC_20830308","title":"Circadian integration of glutamatergic signals by little SAAS in novel suprachiasmatic circuits.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20830308","citation_count":33,"is_preprint":false},{"pmid":"26583378","id":"PMC_26583378","title":"SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.","date":"2015","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/26583378","citation_count":30,"is_preprint":false},{"pmid":"24042052","id":"PMC_24042052","title":"Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS.","date":"2013","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/24042052","citation_count":30,"is_preprint":false},{"pmid":"11517193","id":"PMC_11517193","title":"Coexpression of proprotein convertase SPC3 and the neuroendocrine precursor proSAAS.","date":"2001","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11517193","citation_count":29,"is_preprint":false},{"pmid":"12865150","id":"PMC_12865150","title":"A picoliter 'fountain-pen' using co-axial dual pipettes.","date":"2003","source":"Journal of neuroscience methods","url":"https://pubmed.ncbi.nlm.nih.gov/12865150","citation_count":27,"is_preprint":false},{"pmid":"23536612","id":"PMC_23536612","title":"Probability of detecting Porcine reproductive and respiratory syndrome virus infection using pen-based swine oral fluid specimens as a function of within-pen prevalence.","date":"2013","source":"Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/23536612","citation_count":27,"is_preprint":false},{"pmid":"10756236","id":"PMC_10756236","title":"Complementary DNA cloning and immunologic characterization of a new Penicillium citrinum allergen (Pen c 3).","date":"2000","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10756236","citation_count":26,"is_preprint":false},{"pmid":"28652014","id":"PMC_28652014","title":"Anti-inflammatory effect of Man-Pen-Fang, a Chinese herbal compound, on chronic pelvic inflammation in rats.","date":"2017","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28652014","citation_count":26,"is_preprint":false},{"pmid":"15283695","id":"PMC_15283695","title":"Prohormone convertase 1 (PC1) processing and sorting: effect of PC1 propeptide and proSAAS.","date":"2004","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15283695","citation_count":25,"is_preprint":false},{"pmid":"17276981","id":"PMC_17276981","title":"p53-Dependent Aph-1 and Pen-2 anti-apoptotic phenotype requires the integrity of the gamma-secretase complex but is independent of its activity.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17276981","citation_count":25,"is_preprint":false},{"pmid":"10377244","id":"PMC_10377244","title":"Identification and expression of Pen c 2, a novel allergen from Penicillium citrinum.","date":"1999","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10377244","citation_count":24,"is_preprint":false},{"pmid":"15018810","id":"PMC_15018810","title":"ProSAAS and prohormone convertase 1 are broadly expressed during mouse development.","date":"2002","source":"Brain research. Gene expression patterns","url":"https://pubmed.ncbi.nlm.nih.gov/15018810","citation_count":24,"is_preprint":false},{"pmid":"24941111","id":"PMC_24941111","title":"Pen-2 is essential for γ-secretase complex stability and trafficking but partially dispensable for endoproteolysis.","date":"2014","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24941111","citation_count":24,"is_preprint":false},{"pmid":"12914799","id":"PMC_12914799","title":"An N-terminal fragment of ProSAAS (a granin-like neuroendocrine peptide precursor) is associated with tau inclusions in Pick's disease.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12914799","citation_count":24,"is_preprint":false},{"pmid":"26213948","id":"PMC_26213948","title":"Chitinolytic Bacteria-Assisted Conversion of Squid Pen and Its Effect on Dyes and Pigments Adsorption.","date":"2015","source":"Marine drugs","url":"https://pubmed.ncbi.nlm.nih.gov/26213948","citation_count":22,"is_preprint":false},{"pmid":"28274422","id":"PMC_28274422","title":"Antioxidant and functional properties of protein hydrolysates obtained from squid pen chitosan extraction effluent.","date":"2017","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28274422","citation_count":22,"is_preprint":false},{"pmid":"30824071","id":"PMC_30824071","title":"Ultrafine and carboxylated β-chitin nanofibers prepared from squid pen and its transparent hydrogels.","date":"2019","source":"Carbohydrate polymers","url":"https://pubmed.ncbi.nlm.nih.gov/30824071","citation_count":21,"is_preprint":false},{"pmid":"25414257","id":"PMC_25414257","title":"Pen and Pal are nucleotide-sugar dehydratases that convert UDP-GlcNAc to UDP-6-deoxy-D-GlcNAc-5,6-ene and then to UDP-4-keto-6-deoxy-L-AltNAc for CMP-pseudaminic acid synthesis in Bacillus thuringiensis.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25414257","citation_count":21,"is_preprint":false},{"pmid":"20104881","id":"PMC_20104881","title":"Protein immobilization on Ni(II) ion patterns prepared by microcontact printing and dip-pen nanolithography.","date":"2010","source":"ACS nano","url":"https://pubmed.ncbi.nlm.nih.gov/20104881","citation_count":21,"is_preprint":false},{"pmid":"11082429","id":"PMC_11082429","title":"Tetrapeptide derivatives of [D-Pen(2),D-Pen(5)]-enkephalin (DPDPE) lacking an N-terminal tyrosine residue are agonists at the mu-opioid receptor.","date":"2000","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/11082429","citation_count":21,"is_preprint":false},{"pmid":"28296390","id":"PMC_28296390","title":"Clickable Antifouling Polymer Brushes for Polymer Pen Lithography.","date":"2017","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/28296390","citation_count":21,"is_preprint":false},{"pmid":"15766275","id":"PMC_15766275","title":"Characterization of the reconstituted gamma-secretase complex from Sf9 cells co-expressing presenilin 1, nicastrin [correction of nacastrin], aph-1a, and pen-2.","date":"2005","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15766275","citation_count":21,"is_preprint":false},{"pmid":"23056534","id":"PMC_23056534","title":"Pax6 directly down-regulates Pcsk1n expression thereby regulating PC1/3 dependent proinsulin processing.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23056534","citation_count":20,"is_preprint":false},{"pmid":"22506037","id":"PMC_22506037","title":"Identification of critical amino acids in an immunodominant IgE epitope of Pen c 13, a major allergen from Penicillium citrinum.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22506037","citation_count":20,"is_preprint":false},{"pmid":"18948394","id":"PMC_18948394","title":"Identification of proSAAS homologs in lower vertebrates: conservation of hydrophobic helices and convertase-inhibiting sequences.","date":"2008","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18948394","citation_count":19,"is_preprint":false},{"pmid":"16170650","id":"PMC_16170650","title":"PEN-2 gene mutation in a familial Alzheimer's disease case.","date":"2005","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16170650","citation_count":19,"is_preprint":false},{"pmid":"10734164","id":"PMC_10734164","title":"Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.","date":"2000","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/10734164","citation_count":19,"is_preprint":false},{"pmid":"25643803","id":"PMC_25643803","title":"Quantitative real-time polymerase chain reaction for detecting Mycoplasma hyosynoviae and Mycoplasma hyorhinis in pen-based oral, tonsillar, and nasal fluids.","date":"2015","source":"Journal of veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/25643803","citation_count":19,"is_preprint":false},{"pmid":"25148519","id":"PMC_25148519","title":"ProSAAS-derived peptides are differentially processed and sorted in mouse brain and AtT-20 cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25148519","citation_count":18,"is_preprint":false},{"pmid":"37158502","id":"PMC_37158502","title":"SaaS sRNA promotes Salmonella intestinal invasion via modulating MAPK inflammatory pathway.","date":"2023","source":"Gut microbes","url":"https://pubmed.ncbi.nlm.nih.gov/37158502","citation_count":17,"is_preprint":false},{"pmid":"11964171","id":"PMC_11964171","title":"Molecular and immunological characterization and IgE epitope mapping of Pen n 18, a major allergen of Penicillium notatum.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11964171","citation_count":15,"is_preprint":false},{"pmid":"30858718","id":"PMC_30858718","title":"Painful tumors of the skin: \"CALM HOG FLED PEN AND GETS BACK\".","date":"2019","source":"Clinical, cosmetic and investigational dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/30858718","citation_count":15,"is_preprint":false},{"pmid":"36062045","id":"PMC_36062045","title":"Training Mid-Level Providers to Treat Severe Non-Communicable Diseases in Neno, Malawi through PEN-Plus Strategies.","date":"2022","source":"Annals of global health","url":"https://pubmed.ncbi.nlm.nih.gov/36062045","citation_count":15,"is_preprint":false},{"pmid":"30692224","id":"PMC_30692224","title":"Conditional Inactivation of Pen-2 in the Developing Neocortex Leads to Rapid Switch of Apical Progenitors to Basal Progenitors.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30692224","citation_count":14,"is_preprint":false},{"pmid":"22973949","id":"PMC_22973949","title":"Pen-2 is dispensable for endoproteolysis of presenilin 1, and nicastrin-Aph subcomplex is important for both γ-secretase assembly and substrate recruitment.","date":"2012","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22973949","citation_count":14,"is_preprint":false},{"pmid":"26367462","id":"PMC_26367462","title":"Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26367462","citation_count":14,"is_preprint":false},{"pmid":"32951012","id":"PMC_32951012","title":"The association between dietary patterns and nutritional status in community-dwelling older adults-the PEN-3S study.","date":"2020","source":"European journal of clinical nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/32951012","citation_count":13,"is_preprint":false},{"pmid":"34977932","id":"PMC_34977932","title":"Addressing severe chronic NCDs across Africa: measuring demand for the Package of Essential Non-communicable Disease Interventions-Plus (PEN-Plus).","date":"2022","source":"Health policy and planning","url":"https://pubmed.ncbi.nlm.nih.gov/34977932","citation_count":13,"is_preprint":false},{"pmid":"28881029","id":"PMC_28881029","title":"ProSAAS-derived peptides are regulated by cocaine and are required for sensitization to the locomotor effects of cocaine.","date":"2017","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28881029","citation_count":13,"is_preprint":false},{"pmid":"30940584","id":"PMC_30940584","title":"Immunosensing of breast cancer tumor protein CA 15-3 (carbohydrate antigen 15.3) using a novel nano-bioink: A new platform for screening of proteins in human biofluids by pen-on-paper technology.","date":"2019","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30940584","citation_count":13,"is_preprint":false},{"pmid":"32607937","id":"PMC_32607937","title":"Increased expression and retention of the secretory chaperone proSAAS following cell stress.","date":"2020","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/32607937","citation_count":13,"is_preprint":false},{"pmid":"26044244","id":"PMC_26044244","title":"A Frameshift Mutation in PEN-2 Causes Familial Comedones Syndrome.","date":"2015","source":"Dermatology (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/26044244","citation_count":13,"is_preprint":false},{"pmid":"30726666","id":"PMC_30726666","title":"Neuropeptide PEN and Its Receptor GPR83: Distribution, Signaling, and Regulation.","date":"2019","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30726666","citation_count":13,"is_preprint":false},{"pmid":"30883991","id":"PMC_30883991","title":"Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing.","date":"2019","source":"Respirology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/30883991","citation_count":13,"is_preprint":false},{"pmid":"28039304","id":"PMC_28039304","title":"Allergen Valency, Dose, and FcεRI Occupancy Set Thresholds for Secretory Responses to Pen a 1 and Motivate Design of Hypoallergens.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28039304","citation_count":13,"is_preprint":false},{"pmid":"16310309","id":"PMC_16310309","title":"Haemonchus contortus and Trichostrongylus colubriformis in pen-trials with Javanese thin tail sheep and Kacang cross Etawah goats.","date":"2005","source":"Veterinary parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/16310309","citation_count":13,"is_preprint":false},{"pmid":"28324398","id":"PMC_28324398","title":"Poly(-β-hydroxybutyrate) (PHB) depolymerase PHAZ Pen from Penicillium expansum: purification, characterization and kinetic studies.","date":"2015","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/28324398","citation_count":13,"is_preprint":false},{"pmid":"35527562","id":"PMC_35527562","title":"The proSAAS Chaperone Provides Neuroprotection and Attenuates Transsynaptic α-Synuclein Spread in Rodent Models of Parkinson's Disease.","date":"2022","source":"Journal of Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/35527562","citation_count":12,"is_preprint":false},{"pmid":"33034163","id":"PMC_33034163","title":"Evaluating the usability and safety of the semaglutide single-dose pen-injectors through summative (human factors) usability testing.","date":"2020","source":"Journal of diabetes investigation","url":"https://pubmed.ncbi.nlm.nih.gov/33034163","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52139,"output_tokens":6318,"usd":0.125593},"stage2":{"model":"claude-opus-4-6","input_tokens":9970,"output_tokens":3455,"usd":0.204338},"total_usd":0.329931,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"ProSAAS (encoded by PCSK1N) is a granin-like neuroendocrine peptide precursor that inhibits prohormone convertase 1 (PC1) with an IC50 of 590 nM but does not inhibit PC2; overexpression in AtT-20 cells substantially reduces processing of the endogenous prohormone POMC, and proSAAS is secreted via the regulated pathway.\",\n      \"method\": \"In vitro enzyme inhibition assay with purified proSAAS; overexpression in AtT-20 cells with POMC processing readout; Western blot and radioimmunoassay\",\n      \"journal\": \"The Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro inhibition assay plus cellular overexpression with defined phenotypic readout, foundational discovery paper\",\n      \"pmids\": [\"10632593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The PC1 inhibitory region of proSAAS maps to an 8–12 residue segment near the C terminus containing a critical Lys-Arg sequence; synthetic peptides from this region are competitive inhibitors of PC1 with Ki values of 14–40 nM; inhibition is slow-binding and pH-dependent (pH 5.5 but not 7.4); a GST fusion containing the inhibitory region binds the 71-kDa but not the 85-kDa form of PC1; proSAAS does not inhibit furin, PACE4, PC5A, or PC7.\",\n      \"method\": \"Synthetic peptide inhibition assays, GST pulldown with PC1 forms, in vitro kinetic analysis\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis/deletion mapping and multiple orthogonal methods\",\n      \"pmids\": [\"10816562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The SAAS C-terminal peptide (SAAS CT) contains a hexapeptide sequence that accounts for the vast majority of proSAAS inhibitory potency toward PC1; nanomolar inhibition constants were established; recombinant PC1 can cleave the SAAS CT peptide at a site consistent with cleavage following the inhibitory hexapeptide, indicating that PC1 can process its own inhibitor.\",\n      \"method\": \"Competitive enzyme inhibition assays, in vitro cleavage with recombinant PC1\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with defined kinetics, replicated in separate lab from Fricker et al. 2000\",\n      \"pmids\": [\"10812060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In wild-type mouse brain and pituitary, proSAAS is processed into smaller peptides including little SAAS, PEN, and big LEN; processing is partially impaired in Cpe(fat/fat) mice lacking carboxypeptidase E, leading to accumulation of C-terminally extended PEN, which inhibits PC1 activity.\",\n      \"method\": \"Radioimmunoassay, reverse-phase HPLC, mass spectrometry, gel filtration on wild-type and Cpe(fat/fat) mouse tissues\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods in defined genetic mouse model\",\n      \"pmids\": [\"11094058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The decapeptide proSAAS-(235–244) (VLGALLRVKR) is the most potent competitive PC1 inhibitor (Ki ~9 nM); systematic alanine scanning identified P1 Arg, P2 Lys, and P4 Arg as critical for inhibition; the extended proSAAS-(235–246) is a substrate cleaved by PC1 at KR(244); molecular modeling indicates an extended/poly-l-proline II conformation for the most potent inhibitor.\",\n      \"method\": \"In vitro enzyme inhibition assays, alanine scanning mutagenesis of synthetic peptides, circular dichroism, molecular modeling\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis combined with in vitro kinetics and structural analysis\",\n      \"pmids\": [\"11435430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PC2 or furin can cleave the proSAAS C-terminal peptide in vitro; in PC2 null mouse brains, the proSAAS C-terminal peptide is not processed as efficiently as in wild-type, indicating PC2 is partially responsible for this cleavage in vivo.\",\n      \"method\": \"In vitro cleavage assays with recombinant PC2 and furin, radioimmunoassay on PC2 null mouse brain extracts\",\n      \"journal\": \"Journal of Neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reconstitution plus genetic null mouse model with RIA readout\",\n      \"pmids\": [\"11259501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The N-terminal domain of proSAAS (residues 1–180) lacks the inhibitory C-terminal peptide but still reduces PC1 activity detected in medium when co-expressed in HEK293 or CHO/PC1 cells, suggesting a proSAAS-mediated inactivation mechanism distinct from C-terminal competitive inhibition; proSAAS-(1-225) slows processing of proopiomelanocortin and proenkephalin in AtT-20 cells without depleting processed peptide stores.\",\n      \"method\": \"Transient and stable cotransfection in HEK293, CHO/PC1, and AtT-20 cells; PC1 activity assays; pulse-chase\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean cellular assays with deletion constructs, but mechanism of N-terminal inactivation remains incompletely characterized\",\n      \"pmids\": [\"11719503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ProSAAS-derived peptides (SAAS and LEN) are distributed throughout rat brain and co-localize with PC1 in hippocampus, cerebellum, spinal cord, pituitary, and adrenal medulla; in pancreatic islets, SAAS and LEN are enriched in peripheral (alpha/delta) cells while PC1 is in beta cells, suggesting proSAAS may perform functions beyond PC1 inhibition in some cell types.\",\n      \"method\": \"Immunohistochemistry with antisera to proSAAS-derived peptides and PC1 in rat tissues\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization by immunohistochemistry, functional implications inferred but not directly tested\",\n      \"pmids\": [\"11672612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Processing of proSAAS in AtT-20 and PC12 cells produces little SAAS, PEN, and big LEN peptides via the regulated secretory pathway (secretion stimulated by secretagogues); cleavage does not require PC1 or PC2 (PC12 cells express neither), implying a furin-like enzyme mediates initial processing; long-term secretagogue treatment increases PC1 mRNA without affecting proSAAS mRNA, demonstrating independent regulation.\",\n      \"method\": \"Pulse-chase with [3H]leucine, mass spectrometry, reverse-phase HPLC, radioimmunoassay, secretagogue stimulation in AtT-20 and PC12 cells\",\n      \"journal\": \"The Biochemical Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing cleavage pathway and regulated secretion\",\n      \"pmids\": [\"11742530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ProSAAS (encoded by mouse gene Pcsk1n) is broadly expressed during mouse development from E9, with expression in neural tube-derived tissues early and later restricted to neuroendocrine tissues; expression pattern generally overlaps with PC1, consistent with a role as endogenous PC1 inhibitor during development.\",\n      \"method\": \"Immunohistochemistry with antisera to SAAS and PC1 in mouse embryos E9–E15\",\n      \"journal\": \"Brain Research Gene Expression Patterns\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — localization study; functional role inferred from co-distribution with PC1\",\n      \"pmids\": [\"15018810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In AtT-20 cells, proSAAS expression inhibits both C-terminal PC1 processing and POMC processing under pulse-chase conditions; SAAS CT peptide-propeptide chimeric constructs inhibit zymogen processing in HEK293 cells but not in AtT-20 cells; the PC1 propeptide expressed in trans reduces PC1 C-terminal processing and POMC processing.\",\n      \"method\": \"Pulse-chase analysis in AtT-20 and HEK293 cells; transient and stable transfection\",\n      \"journal\": \"The Journal of Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based assays with multiple constructs, mechanistic interpretation supported by multiple conditions\",\n      \"pmids\": [\"15283695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ProSAAS orthologs in Xenopus and zebrafish share two conserved 14–16 residue hydrophobic segments predicted to form alpha-helices and two conserved basic convertase cleavage site sequences; both non-mammalian proSAAS proteins inhibit mouse PC1/3 with nanomolar Ki values but not human furin, and are cleaved by PC2 and furin in vitro; both exhibit neural and endocrine tissue distributions.\",\n      \"method\": \"In vitro enzyme inhibition assays, in vitro cleavage assays with recombinant convertases, sequence alignment, in situ hybridization, PCR\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of inhibition and cleavage across vertebrate orthologs with multiple methods\",\n      \"pmids\": [\"18948394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In fetal proSAAS knockout mice, prodynorphin undergoes complete adult-like processing instead of the incomplete processing seen in wild-type fetuses where proSAAS intermediates transiently accumulate, demonstrating proSAAS directly inhibits PC1/3 in embryonic brain in vivo; adult proSAAS knockout mice show normal neuropeptide levels but decreased locomotion and male-specific ~10–15% body weight decrease, suggesting adult roles as neuropeptides.\",\n      \"method\": \"Targeted gene knockout mouse model, peptidomics, radioimmunoassay, open-field locomotion testing, glucose tolerance test\",\n      \"journal\": \"Journal of Neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined molecular phenotype (prodynorphin processing) plus behavioral readouts\",\n      \"pmids\": [\"20367757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Little SAAS (a proSAAS-derived peptide) is expressed in the densely retinorecipient central SCN, colocalizes with VIP and GRP, and blockade of NMDA receptors or VIP/GRP cognate receptors does not affect little SAAS-induced phase delays of circadian rhythms, placing little SAAS downstream of light/glutamatergic signaling but independent of VIP/GRP action.\",\n      \"method\": \"Immunohistochemistry with stereological analysis, c-FOS induction, glutamate-stimulated SCN slice recordings, pharmacological blockade\",\n      \"journal\": \"PloS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — combination of localization, genetic context, and pharmacological epistasis in brain slices\",\n      \"pmids\": [\"20830308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Intracerebroventricular injection of antibodies to PEN and big LEN significantly reduces food intake in fasted mice; big LEN produces rapid and reversible inhibition of synaptic glutamate release in hypothalamic paraventricular nucleus neurons in a manner abolished by blocking postsynaptic G protein activity, suggesting involvement of a postsynaptic GPCR and retrograde synaptic messenger.\",\n      \"method\": \"ICV antibody injection with food intake readout in mice; whole-cell patch clamp of parvocellular neurons with G-protein blockade\",\n      \"journal\": \"PloS One\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal in vivo and electrophysiological methods with defined molecular mechanism (GPCR-dependent retrograde signaling)\",\n      \"pmids\": [\"22164236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Pax6 directly binds the Pcsk1n promoter and down-regulates proSAAS (PCSK1N) expression; Pax6 deficiency increases Pcsk1n expression, which in turn reduces PC1/3 C-terminal processing and activity, impairing proinsulin processing; co-knockdown of Pax6 and Pcsk1n rescues proinsulin processing, placing proSAAS downstream of Pax6 in the regulation of glucose metabolism.\",\n      \"method\": \"Luciferase reporter assays, chromatin immunoprecipitation, EMSA, quantitative RT-PCR, RNAi in MIN6 cells, rescue co-transfection experiments\",\n      \"journal\": \"PloS One\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing direct transcriptional regulation and genetic epistasis with functional rescue\",\n      \"pmids\": [\"23056534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ProSAAS efficiently prevents fibrillation of Aβ(1-42) in vitro at molar ratios of 1:10; residues 97–180 are sufficient for anti-aggregation activity against Aβ; recombinant proSAAS in medium and lentiviral proSAAS overexpression both block Aβ(1-42)-induced neurocytotoxicity in Neuro2A cells; proSAAS co-immunoprecipitates with Aβ immunoreactivity in APdE9 mouse brain lysates.\",\n      \"method\": \"In vitro fibrillation assay (ThT fluorescence), deletion mutagenesis, co-immunoprecipitation from mouse brain, cell viability assay with Neuro2A cells, lentiviral overexpression\",\n      \"journal\": \"Journal of Neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution with mutagenesis mapping plus co-IP and cell-based neuroprotection, multiple orthogonal methods\",\n      \"pmids\": [\"24102330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ProSAAS blocks fibrillation of human islet amyloid polypeptide (hIAPP) in vitro and blocks hIAPP-induced cytotoxicity on Rin5f cells; structure-function studies identified the N-terminal region of proSAAS as important for this anti-aggregation activity; overexpression of proSAAS in cells also blocks hIAPP cytotoxicity.\",\n      \"method\": \"In vitro ThT fibrillation assay, cell viability assays, proSAAS overexpression in cells\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reconstitution with functional cell-based validation, single lab\",\n      \"pmids\": [\"24042052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ProSAAS-derived peptides PEN and big LEN colocalize with neuropeptide Y in mouse hypothalamus; initial proSAAS cleavage is mediated by furin (and/or furin-like enzymes) in the Golgi/TGN, generating fragments sorted into distinct vesicles for further processing; mutation of furin consensus sites (P4 Arg→Lys) in proSAAS dramatically increased colocalization of PEN and SAAS in AtT-20 cells.\",\n      \"method\": \"Immunohistochemistry, site-directed mutagenesis of proSAAS furin sites, transfection of mutant proSAAS in AtT-20 cells, confocal colocalization\",\n      \"journal\": \"PloS One\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — site-directed mutagenesis combined with cellular sorting experiments and colocalization analysis\",\n      \"pmids\": [\"25148519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PEN (a proSAAS-derived peptide) binds to and activates GPR83, a GPCR in mouse hypothalamus and Neuro2A cells; reduction of GPR83 expression reduces PEN binding and signaling; in brain regions where GPR83 colocalizes with GPR171 (the bigLEN receptor), coexpression alters signaling properties of each receptor, suggesting functional coupling of the two proSAAS-derived neuropeptide systems.\",\n      \"method\": \"Radioligand binding assays, GPR83 knockdown, signaling assays in Neuro2A cells, colocalization by immunofluorescence, receptor coexpression in cell lines\",\n      \"journal\": \"Science Signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — receptor deorphanization with binding, knockdown, and functional signaling assays, multiple orthogonal approaches\",\n      \"pmids\": [\"27117253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ProSAAS potently inhibits α-synuclein fibrillation in vitro; residues 158–180 (containing a largely conserved element) are critical for this bioactivity; proSAAS-encoding lentivirus blocks α-synuclein-induced cytotoxicity in primary nigral dopaminergic neurons; recombinant proSAAS blocks α-synuclein cytotoxicity in SH-SY5Y cells; proSAAS immunoreactivity is associated with aggregated synuclein deposits in Parkinson's disease substantia nigra.\",\n      \"method\": \"In vitro ThT fibrillation assay, deletion mutagenesis, lentiviral delivery in primary dopaminergic cultures, cell viability assay in SH-SY5Y, immunohistochemistry on human PD brain\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution with mutagenesis, primary neuron neuroprotection, and human brain tissue validation\",\n      \"pmids\": [\"27457957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ProSAAS-derived peptides (big LEN, PEN, little LEN, little SAAS) are decreased in nucleus accumbens and ventral tegmental area following repeated cocaine administration; proSAAS knockout mice fail to sensitize to cocaine and show diminished locomotor sensitization to amphetamine, while conditioned place preference to cocaine is intact, indicating proSAAS peptides contribute to behavioral sensitization but not reward.\",\n      \"method\": \"Quantitative peptidomics in mouse brain regions, proSAAS knockout mice, open-field locomotion and sensitization tests, conditioned place preference\",\n      \"journal\": \"Journal of Neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with quantitative peptidomics and defined behavioral phenotypes\",\n      \"pmids\": [\"28881029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Neuropeptide PEN-GPR83 signaling is implicated in feeding and body weight regulation; GPR83 distribution overlaps with GPR171 (bigLEN receptor) in some brain regions; coexpression alters receptor signaling, supporting a functionally coupled dual neuropeptide system derived from proSAAS (PCSK1N).\",\n      \"method\": \"Review synthesizing binding assays, knockdown, colocalization, and signaling studies from earlier work\",\n      \"journal\": \"ACS Chemical Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — review paper synthesizing prior experimental findings; no new primary experiments\",\n      \"pmids\": [\"30726666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Exposure of Neuro2A cells to ER stressors (tunicamycin, thapsigargin), hypoxic stressor (cobalt chloride), or oxidative stressor (sodium arsenite) increases cellular proSAAS mRNA and protein while paradoxically reducing proSAAS secretion, identifying proSAAS as a stress-responsive secretory chaperone.\",\n      \"method\": \"qRT-PCR, Western blot, ELISA for secreted proSAAS following stressor treatment in Neuro2A cells\",\n      \"journal\": \"Cell Stress & Chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — consistent results across multiple stressors, single lab, single expression/secretion readout methodology\",\n      \"pmids\": [\"32607937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Lentiviral proSAAS overexpression in rat substantia nigra profoundly reduces motor asymmetry caused by AAV-mediated human α-synuclein overexpression, accompanied by preservation of nigral TH-positive cells and striatal TH-positive terminals; proSAAS reduces human α-synuclein levels in nigra and striatum; proSAAS also reduces transsynaptic spread of α-synuclein following vagal AAV injection in mice.\",\n      \"method\": \"Lentiviral/AAV delivery in rat/mouse models, nigral stereology, TH densitometry, immunohistochemistry, behavioral motor battery\",\n      \"journal\": \"Journal of Parkinson's Disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent in vivo rodent models with stereological and behavioral readouts\",\n      \"pmids\": [\"35527562\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PCSK1N encodes proSAAS, a granin-like neuroendocrine precursor that functions as a potent competitive inhibitor of prohormone convertase 1/3 (PC1/3) via a C-terminal hexapeptide-containing segment (Ki ~9–40 nM), is cleaved by furin in the Golgi/TGN and by secretory granule convertases into bioactive peptides (PEN, big LEN, little SAAS, little LEN) that are secreted via the regulated pathway, acts as a secretory chaperone blocking amyloid aggregation (Aβ, α-synuclein, hIAPP), is transcriptionally repressed by Pax6 to regulate proinsulin processing, and generates the neuropeptide PEN which signals through GPR83 to regulate feeding behavior and modulate behavioral sensitization to psychostimulants.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PCSK1N encodes proSAAS, a neuroendocrine secretory precursor that serves dual roles as a potent competitive inhibitor of prohormone convertase 1/3 (PC1/3) and as a precursor to bioactive neuropeptides regulating feeding, circadian rhythms, and psychostimulant sensitization. The C-terminal segment of proSAAS contains a hexapeptide that competitively inhibits PC1/3 with nanomolar affinity (Ki ~9–40 nM), while the N-terminal domain independently reduces PC1/3 activity through a distinct mechanism; initial cleavage by furin in the Golgi/TGN generates fragments (PEN, big LEN, little SAAS, little LEN) that are sorted into regulated secretory granules and further processed by PC2 and carboxypeptidase E [PMID:10632593, PMID:10816562, PMID:25148519, PMID:11094058]. ProSAAS-derived peptide PEN signals through GPR83 and big LEN through GPR171 to regulate hypothalamic feeding circuits and behavioral sensitization to psychostimulants, while the transcription factor Pax6 directly represses PCSK1N to control proinsulin processing via PC1/3 in pancreatic beta cells [PMID:27117253, PMID:28881029, PMID:23056534]. ProSAAS also functions as an anti-amyloid chaperone that blocks fibrillation and cytotoxicity of Aβ, α-synuclein, and hIAPP through its N-terminal/central domain, and lentiviral proSAAS delivery protects nigral dopaminergic neurons and reduces α-synuclein pathology and spread in rodent Parkinson's disease models [PMID:24102330, PMID:27457957, PMID:35527562].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"The discovery that proSAAS is a granin-like PC1 inhibitor that blocks POMC processing and is secreted via the regulated pathway established PCSK1N as an endogenous regulator of prohormone conversion.\",\n      \"evidence\": \"In vitro enzyme inhibition assays with purified proSAAS, overexpression in AtT-20 cells with POMC processing readout\",\n      \"pmids\": [\"10632593\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of selectivity for PC1 over PC2 not structurally resolved\", \"No in vivo loss-of-function data at this stage\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapping the inhibitory domain to a C-terminal hexapeptide-containing segment with Ki values of 9–40 nM and demonstrating competitive, slow-binding, pH-dependent kinetics defined proSAAS as a secretory-granule-compartment-specific PC1/3 inhibitor.\",\n      \"evidence\": \"Systematic synthetic peptide inhibition assays, alanine scanning, GST pulldown with PC1 forms, kinetic analysis across multiple labs\",\n      \"pmids\": [\"10816562\", \"10812060\", \"11435430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of the proSAAS–PC1/3 complex\", \"Slow-binding mechanism not fully explained at the structural level\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identifying proSAAS processing products (little SAAS, PEN, big LEN) in mouse brain and showing impaired processing in Cpe(fat/fat) mice revealed that carboxypeptidase E trims proSAAS-derived peptides and that incompletely processed intermediates retain PC1 inhibitory activity.\",\n      \"evidence\": \"RIA, RP-HPLC, mass spectrometry on wild-type and Cpe(fat/fat) mouse brain/pituitary\",\n      \"pmids\": [\"11094058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological consequences of accumulated PC1-inhibitory intermediates in Cpe-null context not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrating that the N-terminal domain of proSAAS (residues 1–180) reduces secreted PC1 activity independently of the C-terminal inhibitory peptide suggested a second mechanism of PC1 regulation, possibly involving chaperone-like or sorting effects.\",\n      \"evidence\": \"Cotransfection of N-terminal deletion constructs in HEK293, CHO/PC1, and AtT-20 cells with PC1 activity readout\",\n      \"pmids\": [\"11719503\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of N-terminal-mediated PC1 inactivation not identified\", \"No binding partner or structural basis established\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showing that proSAAS processing in PC12 cells (which lack PC1 and PC2) produces the same peptides as neuroendocrine AtT-20 cells established furin-like enzymes as the initiators of proSAAS cleavage in the Golgi/TGN, upstream of secretory granule convertases.\",\n      \"evidence\": \"Pulse-chase, mass spectrometry, RP-HPLC, secretagogue stimulation in AtT-20 and PC12 cells\",\n      \"pmids\": [\"11742530\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific furin-family member responsible not definitively identified in vivo\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"ProSAAS knockout mice revealed that proSAAS inhibits PC1/3 in embryonic brain in vivo (prodynorphin is prematurely fully processed in fetal KO brain) but is largely dispensable for adult neuropeptide processing, while uncovering behavioral roles (reduced locomotion, male-specific body weight decrease).\",\n      \"evidence\": \"Targeted gene knockout mouse, peptidomics, RIA, open-field locomotion, glucose tolerance test\",\n      \"pmids\": [\"20367757\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Compensatory mechanisms in adult KO not characterized\", \"Neuropeptide receptor mediating locomotor phenotype unknown at this point\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying Pax6 as a direct transcriptional repressor of PCSK1N that controls PC1/3 activity and proinsulin processing placed proSAAS within a defined transcriptional circuit governing pancreatic beta-cell function.\",\n      \"evidence\": \"ChIP, EMSA, luciferase reporters, RNAi, and genetic rescue in MIN6 cells\",\n      \"pmids\": [\"23056534\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo validation in Pax6-haploinsufficient or beta-cell-specific Pcsk1n KO mice not performed\", \"Other transcriptional regulators of PCSK1N not surveyed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating that proSAAS blocks fibrillation and cytotoxicity of both Aβ(1-42) and hIAPP, and mapping anti-aggregation activity to the N-terminal/central domain (residues 97–180), established proSAAS as an intracellular anti-amyloid chaperone.\",\n      \"evidence\": \"ThT fibrillation assays, deletion mutagenesis, co-IP from APdE9 mouse brain, cell viability assays in Neuro2A and Rin5f cells\",\n      \"pmids\": [\"24102330\", \"24042052\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of anti-aggregation activity unknown\", \"In vivo relevance in Alzheimer's or type 2 diabetes models not tested at this stage\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Site-directed mutagenesis of furin consensus sites in proSAAS altered vesicular sorting of PEN and SAAS fragments, establishing that furin-mediated cleavage in the Golgi/TGN directs differential sorting of proSAAS-derived peptides into distinct secretory vesicle populations.\",\n      \"evidence\": \"Furin site mutagenesis, transfection in AtT-20 cells, confocal colocalization analysis\",\n      \"pmids\": [\"25148519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of sorting receptors that distinguish PEN-containing from SAAS-containing vesicles unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Deorphanizing GPR83 as the receptor for PEN, and showing that GPR83 and GPR171 (big LEN receptor) functionally interact when coexpressed, established a dual neuropeptide signaling system derived entirely from a single proSAAS precursor.\",\n      \"evidence\": \"Radioligand binding, GPR83 knockdown, signaling assays in Neuro2A cells, receptor coexpression\",\n      \"pmids\": [\"27117253\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling cascades of PEN-GPR83 in hypothalamic neurons not fully mapped\", \"In vivo confirmation via GPR83 KO with PEN challenge not yet reported\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extending the anti-amyloid function to α-synuclein, with mapping of the critical domain (residues 158–180) and demonstration of neuroprotection in primary dopaminergic neurons, positioned proSAAS as a potential therapeutic for synucleinopathies.\",\n      \"evidence\": \"ThT assay, deletion mutagenesis, lentiviral delivery in primary nigral cultures, immunohistochemistry on human PD substantia nigra\",\n      \"pmids\": [\"27457957\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of chaperone action (holdase vs. sequestration) not resolved\", \"Stoichiometry in vivo unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"ProSAAS knockout mice failed to sensitize to cocaine and amphetamine while retaining reward responses, dissecting proSAAS-derived neuropeptide function into sensitization (dependent) versus reward (independent) behavioral components.\",\n      \"evidence\": \"Quantitative peptidomics in nucleus accumbens and VTA, KO mouse locomotor sensitization and conditioned place preference\",\n      \"pmids\": [\"28881029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific proSAAS-derived peptide(s) and receptor(s) mediate sensitization not determined\", \"Circuit-level mechanism not mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"In vivo lentiviral proSAAS delivery protected nigral dopaminergic neurons from α-synuclein toxicity and reduced transsynaptic α-synuclein spread in two independent rodent models, providing preclinical validation of the anti-amyloid chaperone function.\",\n      \"evidence\": \"Lentiviral/AAV delivery in rat substantia nigra and mouse vagus nerve models, stereology, TH densitometry, behavioral motor tests\",\n      \"pmids\": [\"35527562\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term efficacy and dose-response not established\", \"Mechanism of reduced spread (extracellular chaperone vs. intracellular degradation) not distinguished\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of proSAAS interaction with both PC1/3 and amyloidogenic substrates, the identity of sorting receptors directing proSAAS-derived peptides to distinct vesicle populations, and the circuit-level mechanisms by which PEN/GPR83 and bigLEN/GPR171 regulate behavior remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of proSAAS or its complexes\", \"Sorting receptor for proSAAS-derived peptide vesicles not identified\", \"Circuit-specific functions of PEN vs. big LEN signaling not dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 4, 11]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [16, 17, 20, 24]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [8, 18]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 8, 18]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 8, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 2, 3, 12, 15]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [19, 22]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [14, 19, 21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PCSK1\",\n      \"PCSK2\",\n      \"FURIN\",\n      \"CPE\",\n      \"GPR83\",\n      \"PAX6\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}